-
1دورية أكاديمية
المؤلفون: Ou, Sai-Hong Ignatius, Nishio, Makoto, Ahn, Myung-Ju, Mok, Tony, Barlesi, Fabrice, Zhou, Caicun, Felip, Enriqueta, de Marinis, Filippo, Kim, Sang-We, Perol, Maurice, Liu, Geoffrey, Migliorino, Maria Rita, Kim, Dong Wan, Novello, Silvia, Bearz, Alessandra, Garrido, Pilar, Mazieres, Julien, Morabito, Alessandro, Lin, Huamao M., Yang, Hui, Niu, Huifeng, Zhang, Pingkuan, Kim, Edward S.
المساهمون: Kim, Dong Wan
مصطلحات موضوعية: Non-small cell lung cancer, Anaplastic lymphoma kinase, Tumor biomarker, Circulating tumor DNA
العلاقة: Journal of Thoracic Oncology, Vol.17 No.12, pp.1404-1414; https://hdl.handle.net/10371/189058Test; 000892531300009; 2-s2.0-85142143244; 177193
-
2دورية أكاديمية
المؤلفون: Li, Tianhong, LoRusso, Patricia, Maitland, Michael L, Ou, Sai-Hong Ignatius, Bahceci, Erkut, Ball, Howard A, Park, Jung Wook, Yuen, Geoffrey, Tolcher, Anthony
المصدر: Journal of Hematology & Oncology. 9(1)
مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Clinical Research, Lung, Cancer, Clinical Trials and Supportive Activities, 6.1 Pharmaceuticals, 6.2 Cellular and gene therapies, Evaluation of treatments and therapeutic interventions, Administration, Oral, Adult, Aged, Anaplastic Lymphoma Kinase, Antineoplastic Agents, Area Under Curve, Crizotinib, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Resistance, Neoplasm, Fatigue, Female, Humans, Male, Metabolic Clearance Rate, Middle Aged, Nausea, Neoplasms, Protein Kinase Inhibitors, Pyrazoles, Pyridines, Receptor Protein-Tyrosine Kinases, Sulfones, Treatment Outcome, Triazines, Vomiting, Young Adult, ASP3026, ALK inhibitor, Phase I, Pharmacokinetics, Cardiorespiratory Medicine and Haematology, Cardiovascular medicine and haematology, Oncology and carcinogenesis
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/59g2c6g2Test
-
3دورية أكاديمية
المؤلفون: Chen, Joseph, Bearz, Alessandra, Kim, Dong-Wan, Mamdani, Hirva, Bauman, Jessica, Chiari, Rita, Ou, Sai-Hong Ignatius, Solomon, Benjamin J., Soo, Ross A., Felip, Enriqueta, Shaw, Alice T., Thurm, Holger, Clancy, Jill S., Lee, Kimberly, O'Gorman, Melissa, Tanski, Cherie, Pithavala, Yazdi K.
المصدر: Clinical Pharmacokinetics; Feb2024, Vol. 63 Issue 2, p171-182, 12p
مصطلحات موضوعية: ANAPLASTIC lymphoma kinase, NON-small-cell lung carcinoma, PHARMACOKINETICS, P-glycoprotein, PROTEIN-tyrosine kinase inhibitors, CYTOCHROME P-450
-
4دورية أكاديمية
المؤلفون: Soo, Ross A., Tan, Eng Huat, Hayashi, Hidetoshi, Seto, Takashi, Lin, Chia-Chi, Ou, Sai-Hong Ignatius, Kim, Dong-Wan, Liu, Geoffrey, Abbattista, Antonello, Martini, Jean-Francois, Martini, Francois, Wong, Chew Hooi, Toffalorio, Francesca, Solomon, Benjamin J.
المساهمون: Kim, Dong-Wan
مصطلحات موضوعية: FUSION VARIANTS, SINGLE-ARM, OPEN-LABEL, INHIBITOR, REARRANGEMENT, MULTICENTER, CRIZOTINIB, GENE, ROS1, Lorlatinib, Asian, Non-small cell lung cancer, Tyrosine kinase inhibitor, Anaplastic lymphoma kinase
العلاقة: Lung Cancer, Vol.169, pp.67-76; https://hdl.handle.net/10371/184609Test; 000814794800003; 2-s2.0-85131633980; 165760
-
5دورية أكاديمية
المؤلفون: Hrustanovic, Gorjan, Olivas, Victor, Pazarentzos, Evangelos, Tulpule, Asmin, Asthana, Saurabh, Blakely, Collin M, Okimoto, Ross A, Lin, Luping, Neel, Dana S, Sabnis, Amit, Flanagan, Jennifer, Chan, Elton, Varella-Garcia, Marileila, Aisner, Dara L, Vaishnavi, Aria, Ou, Sai-Hong I, Collisson, Eric A, Ichihara, Eiki, Mack, Philip C, Lovly, Christine M, Karachaliou, Niki, Rosell, Rafael, Riess, Jonathan W, Doebele, Robert C, Bivona, Trever G
المصدر: Nature Medicine. 21(9)
مصطلحات موضوعية: Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Cancer, Anaplastic Lymphoma Kinase, Cell Line, Tumor, Drug Resistance, Neoplasm, Dual Specificity Phosphatase 6, Humans, Lung Neoplasms, Mitogen-Activated Protein Kinase Kinases, Mitogen-Activated Protein Kinases, Oncogene Proteins, Fusion, Proto-Oncogene Proteins, Proto-Oncogene Proteins p21(ras), Receptor Protein-Tyrosine Kinases, ras Proteins, Medical and Health Sciences, Immunology, Biomedical and clinical sciences, Health sciences
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/2wf92920Test
-
6دورية أكاديمية
المؤلفون: Ou, Sai-Hong Ignatius, Bazhenova, Lyudmila, Camidge, D. Ross, Solomon, Benjamin J., Herman, June, Kain, Tatiana, Bang, Yung-Jue, Kwak, Eunice L., Shaw, Alice T., Salgia, Ravi, Maki, Robert G., Clark, Jeffrey W., Wilner, Keith D., Iafrate, A. John
المساهمون: 방영주, Bang, Yung-Jue
مصطلحات موضوعية: 18-FDG PET/CT, Adenocarcinoma of the lung, ALK positive NSCLC, Crizotinib (PF02341066), ALK FISH testing, Anaplastic lymphoma kinase
العلاقة: Journal of Thoracic Oncology, Vol.5 No.12, pp.2044-2046; 119317; https://hdl.handle.net/10371/173113Test; 2-s2.0-78650436429; 000284579200029
-
7دورية أكاديمية
المؤلفون: Kim, Edward S, Barlesi, Fabrice, Mok, Tony, Ahn, Myung-Ju, Shen, Junwu, Zhang, Pingkuan, Ou, Sai-Hong Ignatius
المصدر: Future Oncology; May2021, Vol. 17 Issue 14, p1709-1719, 11p
-
8دورية أكاديمية
المؤلفون: Ou, Sai-Hong Ignatius1,2 Ignatius.ou@uci.edu, Weitz, Michael3, Jalas, John R.4, Kelly, Daniel F.5, Wong, Vanessa1, Azada, Michele C.1, Quines, Oliver1, Klempner, Samuel J.1,2
المصدر: Lung Cancer (01695002). Jun2016, Vol. 96, p15-18. 4p.
مصطلحات موضوعية: *ANAPLASTIC lymphoma kinase, *BRAIN metastasis, *NON-small-cell lung carcinoma, *CANCER radiotherapy, *CANCER invasiveness, *HISTORY of medicine, *PATIENTS, *THERAPEUTICS
-
9دورية أكاديمية
المؤلفون: Ou, Sai‐Hong Ignatius1, Tang, Yiyun2, Polli, Anna3, Wilner, Keith D.2, Schnell, Patrick4
المصدر: Cancer Medicine. Apr2016, Vol. 5 Issue 4, p617-622. 6p.
مصطلحات موضوعية: *HEART beat, *CRIZOTINIB, *ANAPLASTIC lymphoma kinase, *BRADYCARDIA, *LOGISTIC regression analysis, *THERAPEUTICS
-
10دورية أكاديمية
المؤلفون: Tianhong Li, LoRusso, Patricia, Maitland, Michael L., Ou, Sai-Hong Ignatius, Bahceci, Erkut, Ball, Howard A., Jung Wook Park, Yuen, Geoffrey, Tolcher, Anthony
المصدر: Journal of Hematology & Oncology; 3/10/2016, Vol. 9, p1-9, 9p
مصطلحات موضوعية: PHARMACOKINETICS, ANTINEOPLASTIC agents, ANAPLASTIC lymphoma kinase, NON-small-cell lung carcinoma, CANCER treatment, PATIENTS, THERAPEUTICS